Model fusion, the next phase in developing animal models for Parkinson's disease
- PMID: 17449461
- DOI: 10.1007/BF03033569
Model fusion, the next phase in developing animal models for Parkinson's disease
Abstract
Within the past 25 years, discoveries of environmental and monogenetic forms of parkinsonism have shaped the direction of Parkinson's disease (PD) research and development of experimental systems to study PD. In this review, we outline a remarkable array of in vivo models available, with particular emphasis on their benefits and pitfalls and the contribution each has made to enhance our understanding of pathological mechanisms involved in PD. Further, we discuss the increasingly popular approach of "model fusion" to create a new generation of animal systems in which to study gene-environment interactions, and the usefulness of such models in capturing the most common events underlying PD.
Similar articles
-
Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies.CNS Neurol Disord Drug Targets. 2013 Aug;12(5):680-97. doi: 10.2174/18715273113129990059. CNS Neurol Disord Drug Targets. 2013. PMID: 23469840
-
Gene-environment interactions in Parkinson's disease and other forms of parkinsonism.Neurotoxicology. 2010 Sep;31(5):598-602. doi: 10.1016/j.neuro.2010.04.007. Epub 2010 Apr 27. Neurotoxicology. 2010. PMID: 20430055 Review.
-
Models of Parkinson's Disease with Special Emphasis on Drosophila melanogaster.CNS Neurol Disord Drug Targets. 2018;17(10):757-766. doi: 10.2174/1871527317666180820164250. CNS Neurol Disord Drug Targets. 2018. PMID: 30129420 Review.
-
Engineered modeling and the secrets of Parkinson's disease.Trends Neurosci. 2001 Nov;24(11 Suppl):S49-55. doi: 10.1016/s0166-2236(00)01984-6. Trends Neurosci. 2001. PMID: 11881746 Review.
-
Animal models of Parkinson's disease.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S183-5. doi: 10.1016/S1353-8020(11)70057-8. Parkinsonism Relat Disord. 2012. PMID: 22166429 Review.
Cited by
-
Autonomic dysfunction in Parkinson disease and animal models.Clin Auton Res. 2019 Aug;29(4):397-414. doi: 10.1007/s10286-018-00584-7. Epub 2019 Jan 2. Clin Auton Res. 2019. PMID: 30604165 Free PMC article. Review.
-
Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Genes Brain Behav. 2008 Mar;7(2):129-51. doi: 10.1111/j.1601-183X.2007.00342.x. Epub 2007 Aug 3. Genes Brain Behav. 2008. PMID: 17680806 Free PMC article. Review.
-
α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.J Mol Neurosci. 2010 Oct;42(2):243-54. doi: 10.1007/s12031-010-9378-1. Epub 2010 May 13. J Mol Neurosci. 2010. PMID: 20464527
-
Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism.Int J Mol Sci. 2021 Jan 21;22(3):1045. doi: 10.3390/ijms22031045. Int J Mol Sci. 2021. PMID: 33494262 Free PMC article. Review.
-
Parkinson's disease: is it a toxic syndrome?Neurol Res Int. 2010;2010:103094. doi: 10.1155/2010/103094. Epub 2010 Sep 5. Neurol Res Int. 2010. PMID: 21152209 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous